Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FENXM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,367
Award facts
- Contract value 100% obligated
- $23,367.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,367.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on December 9, 2025, with an ultimate completion date of December 17, 2025, was made without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, distributing a comprehensive range of pharmaceutical products and medical consumables including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical devices to support Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $500 million ceiling value extending through December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy establishing multiple regional prime vendor contractors to supply recurring medical needs to military healthcare facilities worldwide. As a single-award prime vendor contractor under this framework, DMS Pharmaceutical Group leverages its established performance record to fulfill the diverse and specialized pharmaceutical requirements of the Department of Defense medical system globally, with no subcontractor relationships identified in the award documentation.
Quick answers
Who was awarded contract SPE2DU26FENXM?
SPE2DU26FENXM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DU26FENXM worth?
The government has obligated $23,367 on SPE2DU26FENXM.
Is contract SPE2DU26FENXM an order under another contract?
Yes. SPE2DU26FENXM is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FENXM competed?
The extent of competition for SPE2DU26FENXM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award